dihexa long term safety The Peptide Craze EllieMD | Dihexa
Description
Complete IGF-1 LR3 guide covering dosing protocols, cycle lengths, stacking strategies, and expected results

Reported side effects Mild headache or fatigue typically transient during initial use Mild gastrointestinal discomfort reported in some oral formulation users Sleep disruption or irritability potential sign of overstimulation Theoretical safety concerns Critical note: Because Dihexa activates the HGF/c-Met pathway which promotes cellular growth and repair there is a theoretical concern that it could potentially stimulate unwanted cell proliferation in individuals with active cancer or high cancer risk

Transformation downstream of the c-MET receptor is mediated by the phosphorylation of Janus kinase 1 (JNK), which occurs via binding to CRK [Garcia-Guzman et al
Ueyama N
